{"article": [{"url": "https://www.marketwatch.com/story/johnson-johnson-stock-falls-tuesday-still-outperforms-market-01602015934", "published": 1602002000.0, "headline": "Johnson & Johnson stock falls Tuesday, still outperforms market", "body": "Shares of Johnson & Johnson JNJ, +1.39% slipped 1.33% to $146.26 Tuesday, on what proved to be an all-around grim trading session for the stock market, with the S&P 500 Index SPX, +0.87% falling 1.40% to 3,360.97 and Dow Jones Industrial Average DJIA, +0.56% falling 1.34% to 27,772.76. Johnson & Johnson closed $10.74 below its 52-week high ($157.00), which the company achieved on April 23rd. Despite its losses, the stock outperformed some of its competitors Tuesday, as Roche Holding AG Part. Cert. RHHVF, +2.93% fell 2.14% to $344.27, Merck & Co. Inc. MRK, -0.14% fell 1.98% to $79.63, and Pfizer Inc. PFE, -0.27% fell 1.58% to $36.17. Trading volume (5.0 M) remained 798,178 below its 50-day average volume of 5.8 M. Editor's Note: This story was auto-generated by Automated Insights using data from Dow Jones and FactSet. See our market data terms of use."}]}